Synthesis of the indole core structures of conophylline

Journal of Heterocyclic Chemistry

Volumn 45, Issue 6, 2008, Pages 1803-1808

  Ando, Shin ^a   Okamoto, Yoshinari ^a   Umezawa, Kazuo ^b   Otsuka, Masami ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3,4 DIMETHOXY 5 METHOXYMETHOXY 2 NITROPHENYL)METHANOL; 2,3 DIMETHOXY 1 METHOXYMETHOXY 4 NITRO 5 (2 NITROETHENYL)BENZENE; 3,4 DIMETHOXY 5 METHOXYMETHOXY 2 NITROBENZALDEHYDE; 6,7 DIMETHOXY 5 METHOXYMETHOXY 1H INDOLE; ANTIDIABETIC AGENT; BENZENE DERIVATIVE; CONOPHYLLINE; INDOLE DERIVATIVE; METHYL 2 AZIDO 3 (4 METHOXYMETHOXYPHENYL)PROPENOATE; METHYL 3 (2 NITROETHYL) 6 METHOXYMETHOXY 1H INDOLE 2 CARBOXYLATE; METHYL 3 [2 (BENZOYLAMINO)ETHYL] 6 METHOXYMETHOXY 1H INDOLE 2 CARBOXYLATE; METHYL 3 FORMYL 6 METHOXYMETHOXY 1H INDOLE 2 CARBOXYLATE; METHYL 3 HYDROXY 4 METHOXY 5 METHOXYMETHOXY 2 NITRO BENZOATE; METHYL 3,4 DIMETHOXY 5 METHOXYMETHOXY 2 NITRO BENZOATE; METHYL 3,5 DIHYDROXY 4 METHOXY 2 NITRO BENZOATE; METHYL 6 METHOXYMETHOXY 1H INDOLE 2 CARBOXYLATE; N BENZOYL N [2 (2 FORMYL 6 METHOXYMETHOXY 1H INDOL 3 YL)ETHYL]AMINE; N BENZOYL N [2 (2 HYDROXYMETHYL 6 METHOXYMETHOXY 1H INDOL 3 YL)ETHYL]AMINE; N BENZOYL N [2 (6 METHOXYMETHOXY 2 VINYL 1H INDOL 3 YL)ETHYL]AMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; DRUG STRUCTURE; SYNTHESIS; TABERNAEMONTANA; TABERNAEMONTANA DIVARICATA;

EID: 57749114630     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570450638     Document Type: Article

References (22)

1. Kam, T.-S.; Loh, K.Y.; Wet, C. J. Nat. Prod. 1993, 56, 1865.
2. [a] Umezawa, K.; Taniguchi, T.; Tomi, M.; Ohse, T.; Tatsumi, N.; Yamamoto, T.; Koyano, T.; Ishizuka, M. Drugs. Exptl. Clin. Res. 1996, 22, 35.
3. [b] Amino, N.; Ohse, T.; Kayano, T.; Umezawa, K. Anticancer Res. 1996, 16, 55.
4. [c] Hirosawa, T.; Kondo, K.; Hishiki, T.; Koshizawa, S.; Umezawa, K.; Nagakawa, A. Neurosci. Lett. 1997, 238, 115.
5. [d] Irie, T.; Kubushiro, K.; Suzuki, K.; Tsukazaki, K.; Umezawa, K.; Nozawa, S. Anticancer Res. 1999, 19, 3061.
6. [a] Umezawa, K; Hiroki, A.; Kawakami, M.; Naka, H.; Takei, I.; Ogata, T.; Kojima, I.; Koyano, T.; Kowithayakorn, T.; Pang, H. -S.; Kam, T. -S. Biomed. Pharmacother. 2003, 57, 341.
7. [b] Takatsuka, H.; Umezawa, K. Biomed. Pharmacother. 2004, 58, 610.
8. [c] Ogata, T.; Li, L.; Yamada, S.; Yamamoto, Y.; Tanaka, Y.; Takei, I.; Umezawa, K.; Kojima, I. Diabetes 2004, 53, 2596.
9. [d] Kojima, I.; Umezawa, K. Int. J. Biochem. Cell. Biol. 2006, 38, 923.
10. [e] Kitamura, R.; Ogata, T.; Tanaka, Y.; Motoyoshi, K.; Seno, M.; Takei, I.; Umezawa, K.; Kojima, I. Endocr. Journal. 2007, 54, 255.
11. Kam, T. -S.; Pang, H. -S.; Lim, T. -M. Org. Biomol. Chem. 2003, 1, 1292.
12. Alam, A.; Takaguchi, Y.; Ito, H.; Yoshida, T.; Tsuboi, S. Tetrahedron 2005, 61, 1909.
13. Anuradha, V.; Srinivas, P. V.; Aparna, P.; Rao, J. M. Tetrahedron Lett. 2006, 47, 4933.
14. Magnus, P.; Gazzard, L.; Hobson, L.; Payne, A. H.; Rainey, T. J.; Westlund, N.; Lynch, V. Tetrahedron 2002, 58, 3423.
15. Hemetsburger, H.; Knittel, D.; Weidmann, H. Monashefte für Chemie 1969, 100, 1599.
16. Jung, S. -H.; Cho, S. -H.; Dang, T. H.; Lee, J. -H.; Ju, J. -H.; Kim, M. -K.; Lee, S. -H.; Ryu, J. -C.; Kim, Y. Eur. J. Med. Chem. 2003, 38, 537.
17. Bennasar, M. -L.; Roca, T.; Ferrando, F. J. Org. Chem. 2005, 70, 9077.
18. [a] Young, E. H. P. J. Chem. Soc. 1958, 3493.
19. [b] Urrutia, A.; Rodríguez, J. G. Tetrahedron, 1999, 55, 11095.
20. [c] Aulaskari, P.; Ahlgrén, M.; Vainiotalo, P.; Pohjala, E. J. Heterocyclic. Chem. 2000, 37, 87.
21. [d] Aulaskari, P.; Pohjala, E.; Vainiotalo, P. Synth. Commun., 1997, 27, 2627.
22. Liu, J. -J.; Hino, T.; Tsuruoka, A.; Harada, N.; Nakagawa, M. J. Chem. Soc., Perkin Trans. 1 2000, 3487.